BioCentury | Jan 11, 2019
Company News

Trigr gets rights to ABL's bispecific antibody

...ABL Bio Inc. (KOSDAQ:298380) granted Trigr Therapeutics Inc. (Irvine, Calif.) exclusive rights to TR009 (formerly ABL001, NOV1501), a...
...ABL Bio Inc. (KOSDAQ:298380), Seongnam, South Korea Trigr Therapeutics Inc., Irvine, Calif. Business: Cancer, Ophthalmology Chris Lieu ABL Bio Inc. Trigr Therapeutics Inc. ABL001 NOV1501 TR009...
BioCentury | Nov 7, 2018
Emerging Company Profile

ABL bispecifics

...chemotherapy. In July, ABL licensed ex-Korea rights to five of its six programs to California-based Trigr Therapeutics Inc....
...University Corporate partners: Yuhan Corp., Dong-A ST Co. Ltd., I-Mab Biopharma, LegoChem Biosciences Inc. and Trigr Therapeutics Inc....
...Denali Therapeutics Inc. (NASDAQ:DNLI), South San Francisco, Calif. OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), Redwood City, Calif. Trigr Therapeutics Inc....
BioCentury | Jul 13, 2018
Company News

Korean company ABL out-licenses antibody programs to U.S.

...ABL Bio Inc. (Seongnam, South Korea) granted Trigr Therapeutics Inc. (Irvine, Calif.) global rights to five of its...
...ABL Bio Inc., Seongnam, South Korea Trigr Therapeutics Inc., Irvine, Calif. Business: Antibodies Elizabeth S. Eaton ABL301 asciminib (ABL001) ABL Bio Inc. Trigr Therapeutics Inc. Delta...
BioCentury | Jul 2, 2018
Company News

Korean company ABL out-licenses antibody programs to U.S.

...ABL Bio Inc. (Seongnam, South Korea) granted Trigr Therapeutics Inc. (Irvine, Calif.) global rights to five of its...
Items per page:
1 - 4 of 4
BioCentury | Jan 11, 2019
Company News

Trigr gets rights to ABL's bispecific antibody

...ABL Bio Inc. (KOSDAQ:298380) granted Trigr Therapeutics Inc. (Irvine, Calif.) exclusive rights to TR009 (formerly ABL001, NOV1501), a...
...ABL Bio Inc. (KOSDAQ:298380), Seongnam, South Korea Trigr Therapeutics Inc., Irvine, Calif. Business: Cancer, Ophthalmology Chris Lieu ABL Bio Inc. Trigr Therapeutics Inc. ABL001 NOV1501 TR009...
BioCentury | Nov 7, 2018
Emerging Company Profile

ABL bispecifics

...chemotherapy. In July, ABL licensed ex-Korea rights to five of its six programs to California-based Trigr Therapeutics Inc....
...University Corporate partners: Yuhan Corp., Dong-A ST Co. Ltd., I-Mab Biopharma, LegoChem Biosciences Inc. and Trigr Therapeutics Inc....
...Denali Therapeutics Inc. (NASDAQ:DNLI), South San Francisco, Calif. OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), Redwood City, Calif. Trigr Therapeutics Inc....
BioCentury | Jul 13, 2018
Company News

Korean company ABL out-licenses antibody programs to U.S.

...ABL Bio Inc. (Seongnam, South Korea) granted Trigr Therapeutics Inc. (Irvine, Calif.) global rights to five of its...
...ABL Bio Inc., Seongnam, South Korea Trigr Therapeutics Inc., Irvine, Calif. Business: Antibodies Elizabeth S. Eaton ABL301 asciminib (ABL001) ABL Bio Inc. Trigr Therapeutics Inc. Delta...
BioCentury | Jul 2, 2018
Company News

Korean company ABL out-licenses antibody programs to U.S.

...ABL Bio Inc. (Seongnam, South Korea) granted Trigr Therapeutics Inc. (Irvine, Calif.) global rights to five of its...
Items per page:
1 - 4 of 4